| Old Articles: <Older 4321-4330 Newer> |
 |
The Motley Fool November 6, 2007 Brian Lawler |
The Two Sides of Endo It has been a mixed third quarter for Endo Pharmaceuticals. On the financial side of things the company performed well; on the research and development side, things are not as good.  |
The Motley Fool November 6, 2007 Brian Lawler |
No Surprise That Vertex Has Competition Did shares of Vertex Pharmaceuticals slump on competition concerns?  |
The Motley Fool November 6, 2007 Brian Orelli |
Getting Vaccinated Alongside Mom Merck presents data supporting use of its HPV vaccine in older women. The drugmaker may have a tough marketing job ahead of it.  |
AFP eWire November 5, 2007 |
Senate Considering Nonprofit Hospital Reforms Republican staff for the Senate Finance Committee has developed a series of proposed reforms related to governance, meeting community needs and levels of charitable care.  |
The Motley Fool November 5, 2007 Brian Orelli |
Can't Beat BD's Steady Growth Fourth-quarter results offer more of the same steady growth for medical technology company Becton, Dickinson.  |
The Motley Fool November 5, 2007 Brian Orelli |
Last Look at Mini-Mylan An impending merger with Merck's KGaA's generic drug business should more than double revenue at Mylan.  |
The Motley Fool November 5, 2007 Brian Lawler |
Encysive in a No-Win Situation Encysive Pharmaceuticals needs help to get its lead drug onto the U.S. market in time to turn its financials around. Investors, take note.  |
The Motley Fool November 5, 2007 Brian Lawler |
Follow the Trend With Novo Nordisk The future is bright for Danish drugmaker Novo Nordisk. The worldwide leader in diabetes treatments turns in another good quarter.  |
The Motley Fool November 5, 2007 Brian Lawler |
King's Abuse-Resistant Bet King Pharmaceuticals signs a development deal with Acura Pharmaceuticals to produce abuse-resistant painkillers. Investors, take note.  |
Managed Care October 2007 Martin Sipkoff |
Asheville's Legacy: Pharmacy Moves From Dispensing to Clinical Management It is an idea whose time has finally come: Today's clinical pharmacists are involved in virtually all aspects of medical care.  |
| <Older 4321-4330 Newer> Return to current articles. |